ALISE BARTOLUCCI: Open Payments
NPI 1255751509 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 27 payments from 10 companies in 2025. Trend: 2023 $767 · 2024 $771 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $163 |
| Abbott Laboratories | 1 | $133 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| Alnylam Pharmaceuticals Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $33 |
| HEARTFLOW, INC. | 1 | $22 |
Products named: VYNDAQEL, CARDIOMEMS, LEQVIO, JARDIANCE, FUROSCIX, Kerendia, Attruby, REPATHA.
Industry payments across MA — which companies pay providers there.
